Duke Capital Ltd - Guernsey-based provider of royalty finance to companies in UK and Europe - Sells investment in Fairmed Healthcare AG, a Switzerland-based provider of high-quality generic prescription medicines, over-the-counter pharmaceuticals, dermocosmetics and dietary supplements in various EU countries. Receives EUR11.4 million cash providing Duke with additional liquidity for new deployments into its pipeline of long-established, profitable businesses. Notes payment of EUR6.0 million has been received with the balance of EUR5.4 million to be paid by March 31.
Current stock price: 30.00 pence, up 1.0% in London on Thursday
12-month change: down 9.1%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Duke Capital (DUKE)